Collaborative effort to reevaluate use of puberty-blocking drug in gender dysphoric minors: Joint initiative by Ministry of Health and Ministry of Family

Schillaci and Roccella developing new guidelines for triptorelin in managing dysphoria

The Ministry of Health and Ministry of Family have come together to discuss the use of triptorelin, a puberty-blocking drug, in minors with gender dysphoria. Ministers Orazio Schillaci and Eugenia Roccella are leading this initiative, bringing together a team of technicians and experts to develop new guidelines based on scientific literature and experiences from other countries.

A joint statement from the two ministries announced this initiative and highlighted the work that has been done so far to address gender dysphoria and the use of blockers. The statement mentions the involvement of scientific societies, the National Bioethics Committee, and a survey conducted in various regions regarding the clinical and financial aspects of prescribing triptorelin.

The press release also outlines the request for a report from AIFA on the therapeutic indications for the drug. This collaborative effort aims to reexamine the issue of using triptorelin in cases of gender dysphoria in minors and establish clear guidelines for its use in the future. The composition of the expert panel will be finalized in the coming days to further advance this important discussion.

Sophia Reynolds

As a content writer at newsloki.com, I'm always on the lookout for the next intriguing story to share with our audience. With a passion for crafting engaging and informative content, I delve into a variety of topics ranging from breaking news to feature pieces. My goal is to captivate readers through my words and keep them coming back for more. When I'm not typing away at my keyboard, you can find me exploring new coffee shops, diving into a good book, or taking long walks in nature. Join me on this journey of storytelling and discovery at newsloki.com - where every word has the power to inform and inspire.

Learn More →

Leave a Reply